HomeResources to support you
The COVID-19 vaccine is now available for anyone living or working in Alaska who is age 16 or older, however please note that resources are still in the process of being updated to reflect recent changes in vaccine eligibility. Updated information will be be posted soon.
COVID-19 vaccine pages
- Alaska COVID-19 Vaccine Main Page
- Vaccine Safety
- Frequently Asked Questions
- Communication and Education Toolkit
- Healthcare workers
Ordering, storage and handling
Ordering and transferring
- How to order COVID-19 vaccine (PDF)
- Transfer vaccine form (PDF)
- COVID Vaccine Temperature Excursion Report (PDF)
Storage and handling
- Vaccine Handling Toolkit
- How to Reconcile and Return Spoiled COVID-19 Vaccine Doses (PDF)
- Temperature Monitoring for Ultra-Cold in Fahrenheit (PDF)
- Temperature Monitoring for Ultra-Cold in Celsius (PDF)
- Temperature Monitoring for Freezer in Fahrenheit (PDF)
- Temperature Monitoring for Freezer in Celsius (PDF)
- Temperature Monitoring for Refrigerator in Fahrenheit (PDF)
- Temperature Monitoring for Refrigerator in Celsius (PDF)
- Dry Ice Safety (PDF)
- Vaccine Administration and Storage and Handling Guide (CDC)
- Janssen Vaccine Storage and Handling Summary
- Janssen Vaccine Storage and Handling Labels
- Janssen Transport Guidance Summary
- Janssen Transport Temperature Log
Dispensing clinic provider materials
- Vaccine Eligibility Attestation and Script (PDF)
Providers need to sign and return this form to their TAA stating that they will confirm vaccine recipient’s eligibility. - Printed material order form (PDF)
- COVID-19 vaccine consent form (PDF)
- See communications toolkit for more materials
Patient safety
- Reporting adverse events to the Vaccine Adverse Event Reporting System (VAERS)
- Anaphylaxis handout (PDF)
- Interim Considerations: Preparing for the Potential Management of Anaphylaxis at COVID-19 Vaccination Sites (CDC)
- 12 things Jurisdictions Need to Know About VAERS (PDF)
- Vaccine safety application, V-Safe, information sheet (PDF)
(Will be provided in printed form with supplies) - Vaccine safety application, V-Safe, poster (PDF)
(Will be provided in printed form with supplies) - V-Safe flyer and info sheet now available in Korean, Spanish, Simplified Chinese, and Vietnamese
- V-Safe FAQ
Stay informed about vaccines
Guidance
The CDC COVID-19 Vaccination Program Provider Agreement expressly incorporates all recommendations, requirements, and other guidance that the agreement specifically identifies. Organizations must monitor such identified guidance for updates. Organizations must comply with such updates. Updates will be posted on the following webpages:
- CDC Covid-19 Vaccine Information (CDC)
- ACIP Vaccine Recommendations and Resources (CDC)
- Immunization Information Systems (CDC)
- Pfizer-BioNTech COVID-19 Vaccine Resources
Product information by vaccine
- Pfizer/Moderna Dr. Zink Letter to Vaccine Providers on Extracting Doses -- January 5, 2021 (PDF)
- Pfizer-BioNTech COVID-19 vaccine materials
- Moderna COVID-19 vaccine materials
- Moderna—OnePage (PDF)
- Pfizer—One Page (PDF)
- Pfizer Vaccine Preparation Poster (PDF)
- Janssen COVID-19 Vaccine
Literature about newly available vaccines
- CDC Pfizer MMWR, “The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020â€
- CDC Moderna MMWR, “The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020â€
- CDC Janssen MMWR, "The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021"
- Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States
- Review of Available Literature Related to COVID-19 Vaccine Development in US (PDF)
- Additional information related to the interim recommendation for Pfizer-BioNTech (CDC)
- Vaccine Authorization Process Overview (ASTHO)
Presentations about newly available vaccines
- Dr. Jeffrey G Demain Presentation on Anaphylaxis and mRNA COVID-19 Vaccine
- CDC presentation about the Pfizer-BioNTech COVID-19 Vaccine (PDF)
- CDC presentation about the Use of mRNA COVID-19 Vaccines
- Presentation by Dr. Jay Butler, Deputy Director for CDC Infectious Disease: Addressing Alaska Health Care Stakeholders about the COVID-19 Vaccine
Learn the latest about vaccine in Alaska
- Register for DHSS newsletters and updates, such as the COVID-19 Vaccine Update
Alaska planning and distribution resources
- COVID-19 Vaccine Cost Fact Sheet (PDF)
- Long-Term Care Facility Distribution Infographic (PDF)
- COVID-19 Vaccine in Alaska: Information for Community Leaders and Emergency Managers (PDF)
- POD training slides (PDF)
- Alaska Draft COVID-19 Vaccination Plan (PDF)
Alaska healthcare partner resources
School-based vaccination resources
Communications resources
- Vaccination information sheet for parents and youth ages 12-15 (PDF)
- School vaccine clinic flyer template (PDF)
- COVID-19 immunization consent school permission slip example (DOC)
School administrator resources
- Letter from State of Alaska Chief Medical Officer Dr. Anne Zink to school staff (PDF)
- FDA memo regarding authorization for Pfizer ages 12+
- Pfizer-BioNTech COVID-19 Vaccine Emergency Use Authorization (PDF)